IRIC discoveries have spurred major advances in understanding the development of cancer and opened the way to the creation of new, more targeted therapeutic solutions. Its publications are a reflection of these accomplishments. They also demonstrate the Institute’s drive and productivity.
NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.Genes Chromosomes Cancer 2018-06-01;57(6):311-319.
Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.Trends Biochem. Sci. 2018-05-04.
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.Cell Rep 2018-05-01;23(5):1476-1490.
Gas-Phase Enrichment of Multiply Charged Peptide Ions by Differential Ion Mobility Extend the Comprehensiveness of SUMO Proteome Analyses.J. Am. Soc. Mass Spectrom. 2018-04-05.
Signaling pathways involved in the regulation of mRNA translation.Mol. Cell. Biol. 2018-04-02.
Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.J. Clin. Invest. 2018-04-02;128(4):1597-1614.
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.Cancer Discov 2018-04-01;8(4):478-497.
Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing.Brain Struct Funct 2018-04-01;223(3):1275-1296.
PML requirement for interferon-induced global cellular SUMOylation.Mol. Cell Proteomics 2018-03-13.